Arie Belldegrun - Significant Ownership

Location
Los Angeles, CA
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by Arie Belldegrun.

Significant Ownership of Arie Belldegrun

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
ALLO Allogene Therapeutics, Inc. Common Stock 5.6% $15.7M $77.4K 12.7M +0.5% Arie Belldegrun, M.D. Sep 30, 2025

Schedules 13D/G Reported by Arie Belldegrun:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Date Filed
* An asterisk sign (*) next to the price indicates that the price is likely invalid.